Diabetic Neuropathy Newswire (Page 6)

Diabetic Neuropathy Newswire (Page 6)

Comprehensive Real-Time News Feed for Diabetic Neuropathy. (Page 6)

Results 101 - 120 of 727 in Diabetic Neuropathy

  1. NeuroMetrix Teams Up With U.S. Pain Foundation To Raise Awareness Of Chronic PainRead the original story

    Aug 28, 2017 | BioSpace

    ... pain on their quality of life. The company also markets DPNCheckA , a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has ...

    Comment?

  2. Microcurrent transcutaneous electric nerve stimulation in painful...Read the original story

    Aug 28, 2017 | CiteULike

    ... it into the document. Diabetes is a common health care problem in western countries. Painful diabetic neuropathy (PDN) might be one of the consequences of long ongoing diabetes; it is estimated that approximately 20% of European diabetic patients ...

    Comment?

  3. Neuropathy-specific alterations in a Mexican population of diabetic patientsRead the original story w/Photo

    Aug 24, 2017 | BioMed Central

    ... more severe co-morbidities [ ], there are few comparative reports in patients with different types of diabetic neuropathy. Here, instead of focusing only on one type of neuropathy or mixing several neuropathies in a single test group, we attempted ...

    Comment?

  4. Smart Strategies for the Growth of - Diabetic Neuropathy Treatment MarketRead the original story w/Photo

    Aug 25, 2017 | SBWire

    Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage.

    Comment?

  5. Alnylam: Q3 Catalysts PlayRead the original story w/Photo

    Aug 23, 2017 | Seeking Alpha

    ... was the mNIS+7 score, and the second primary endpoint was the Norfolk Quality of Life Questionnaire-Diabetic Neuropathy (Norfolk QoL-DN). Each primary endpoint was p <0.0001 and p =0.0006 respectively. In my opinion, Ionis has a strong clinical ...

    Comment?

  6. Czech Republic to hold presidential vote in JanuaryRead the original story w/Photo

    Aug 23, 2017 | Egypt Today

    ... for a president. Zeman is a heavy smoker, a fan of hard liquor and suffers from impaired hearing and diabetic neuropathy, which forces him to walk with a cane. - General election in October - Among the 20 other candidates are former Academy of ...

    Comment?

  7. Global Diabetic Neuropathy Market - Industry Analysis, Size, Share,...Read the original story w/Photo

    Aug 22, 2017 | SBWire

    Currently, the global diabetic neuropathy market is being primarily motivated by changing lifestyles which have directly resulted in unhealthy dietary habits and patterns. To learn further, Market Research Reports Search Engine has included a new report titled "Diabetic Neuropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025", to its vast database.

    Comment?

  8. NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During SleepRead the original story

    Aug 15, 2017 | Customer Interaction Solutions

    ... chronic pain on their quality of life. The company also markets DPNCheck, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has ...

    Comment?

  9. NeuroMetrix Announces Issuance Of New U.S. Patent For Automated...Read the original story

    Aug 14, 2017 | BioSpace

    ... pain on their quality of life. The company also markets DPNCheckA , a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has ...

    Comment?

  10. Alnylam Shoots For The Moon With ApolloRead the original story w/Photo

    Aug 14, 2017 | Seeking Alpha

    ... pivotal trial also had mNIS+7 as a co-primary endpoint, along with the Norfolk quality of life-diabetic neuropathy measure. Ionis has not reported detailed results, only saying that both endpoints reached statistical significance with p values of ...

    Comment?

  11. Cannabis can help with agingRead the original story w/Photo

    Aug 10, 2017 | NewsReview.com

    ... disorder) and THC's anti-inflammatory properties can help with swelling. Cannabis is also good for diabetic neuropathy (nerve pain), according to a 2015 study in the Journal of Pain. The study's lead author Dr. Mark Steve Wallace, chair of the ...

    Comment?

  12. Global Diabetic Neuropathy Sales Market Industry Analysis and Research Report 2017Read the original story

    Aug 10, 2017 | Emailwire.com

    In this report, the global Diabetic Neuropathy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Market Research Hub has recently publicized a new study to its vast repository, which is titled as 'Global Diabetic Neuropathy Sales Market Report 2017'.

    Comment?

  13. August, 8, 2017, PLLR E-NewsletterRead the original story w/Photo

    Aug 8, 2017 | Trial

    ... 54, discovered a small wound on the bottom of the second toe on his left foot. Because of preexisting diabetic neuropathy, he had not felt the wound. He and his supervisor later discovered a tack sticking up deep inside the left shoe. The day after ...

    Comment?

  14. Diabetic Neuropathy Market Analysis, Trends and Forecast Study During ...Read the original story w/Photo

    Aug 7, 2017 | SBWire

    Currently, the global diabetic neuropathy market is being primarily motivated by changing lifestyles which have directly resulted in unhealthy dietary habits and patterns. To learn further, Market Research Reports Search Engine has included a new report titled "Diabetic Neuropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025", to its vast database.

    Comment?

  15. NeuralStem Awarded $~1MM Grant By NIH To Continue Preclinical...Read the original story

    Aug 1, 2017 | BioSpace

    Neuralstem, Inc. , a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded a Phase 2 Small Business Innovation Research grant by the National Institutes of Health of up to $997,068 over two years to conduct preclinical research to evaluate the potential of NSI-189, a novel small molecule compound, for the prevention and treatment of diabetic neuropathy. The research funded by this award will build on a previous study performed in collaboration with Drs.

    Comment?

  16. Md. biopharm gets $1M NIH grant to study drugRead the original story w/Photo

    Aug 2, 2017 | Daily Record

    Neuralstem Inc., a biopharmaceutical company, recently received a grant worth up to nearly $1 million from the National Institutes of Health. The Germantown company received the research grant, to evaluate over two years the ability of its small molecule compound, NSI-189 to prevent and treat diabetic neuropathy.

    Comment?

  17. Global Diabetes Gastroparesis Market by Analysis of Major Industry Segments 2017-2025Read the original story w/Photo

    Aug 1, 2017 | SBWire

    ... causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the vagus nerve, in cases where the blood glucose levels remain high over a longer duration. Diabetes gastroparesis is ...

    Comment?

  18. Diabetes Gastroparesis Market Key Trends 2017 - 2025Read the original story w/Photo

    Jul 31, 2017 | PR-inside.com

    ... causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the vagus nerve, in cases where the blood glucose levels remain high over a longer duration. Diabetes gastroparesis is ...

    Comment?

  19. NeuroMetrix Announces Shipment Of 100,000th Quell Device Since Launch In 2015Read the original story

    Jul 27, 2017 | BioSpace

    ... pain on their quality of life. The company also markets DPNCheckA , a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. The company maintains an active research effort and has ...

    Comment?

  20. Analysts' Weekly Ratings Changes for BioDelivery Sciences InternationalRead the original story w/Photo

    Jul 26, 2017 | AmericanBankingNews.com

    ... the company recently discontinued development of clonidine topical gel for management of painful diabetic neuropathy. BioDelivery's portfolio as well as its pipeline candidates may also face sever competition as it targets a highly genericized and ...

    Comment?